Skip to Content

Month: January 2021

Regeneron says study shows its monoclonal antibody cocktail works against coronavirus variants

Tests on two different variants of the coronavirus show that one of the two monoclonal antibodies in Regeneron’s cocktail therapy can neutralize both, despite the mutations, researchers reported Wednesday. The tests also confirm what other teams of researchers have found: vaccines are likely to protect people against both the variant first seen in Britain and

Continue Reading